Skip to content

Evaluation of the Effect of Pomegranate and Turmeric Mouthwash on Oral Mucositis Due to Chemotherapy

Evaluation of the Effect of Using Mouthwash Solution Containing Hydroalcoholic Extract of Pomegranate and Turmeric on Oral Mucositis Due to Chemotherapy in Cancer Patients, a Triple blind, Randomized, Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200721048159N1
Enrollment
60
Registered
2021-04-10
Start date
2021-05-17
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral mucositis due to antineoplastic therapy. Oral mucositis (ulcerative) due to antineoplastic therapy

Interventions

Intervention 1: Intervention group: Intervention group Herbal mouthwash containing 6.25% hydroalcoholic extract of pomegranate peel and 0.1% hydroalcoholic extract of turmeric, once every 6 hours, 30

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients in the age range of 18 to 65 years Cancer patients with chemotherapy-induced oral inflammation Patients are able to complete a questionnaire and collaborate with the researcher Absence of serious dental problems or teeth damaging the oral mucosa or sharp fillings Do not use dentures Do not use anti-inflammatory and other mouthwash solutions during research No other systemic diseases No history of smoking, drugs and alcohol No oral candidiasis (fungus) or herpes simplex (virus) Do not use cryotherapy for six weeks before the study

Exclusion criteria

Exclusion criteria: Dissatisfaction with participating in the study Participate in another clinical trial at the same time History of allergies to turmeric and pomegranate, lidocaine, antacids, diphenhydramine and dexamethasone Inability of the patient to implement the treatment protocol Patient death due to failure to respond to anticancer therapy Combination therapies such as radiation therapy

Design outcomes

Primary

MeasureTime frame
Grade of mucositis based on WHO scale. Timepoint: Evaluation of grade of mucositis at the beginning of the study, 7 and 14 days after mouthwash containing pomegranate and turmeric extract. Method of measurement: Standard questionnaire and patient examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForouzan Ahmadpour

Khoram-Abad University of Medical Sciences

ahmadpourforoz@yahoo.com+98 66 3312 0239

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026